SCP

SCOPE FLUIDICS GPW LISTED

Website

OVERVIEW FINANCE CONTRACTS DIVIDENDS SHAREHOLDERS

Contracts

All Active Completed

source: current reports (ESPI/EBI) · incomplete data — not every contract is disclosed · 6 contracts in the database

DISCLOSED VALUE 12M

14.4 m PLN

1 of 2 contracts

SHARE OF REVENUE 12M

—

no revenue data in the database

LARGEST COUNTERPARTY

100%

PARP (Hybolic sp. z o.o.)

LONGEST TERM

—

no realization dates

SC ELTA 90 Medical Research SRL (ELTA MR)

undisclosed

Nowa · Ramowa umowa dystrybucyjna systemu BACTEROMIC w Rumunii

Ramowa umowa dystrybucyjna systemu BACTEROMIC w Rumunii

Status

Ongoing

Signing date

—

Term

—

Source announcement →

COMAC Medical Ltd.

1 m EUR

Nowa · przeprowadzenie badań klinicznych Panelu PBC systemu BACTEROMIC (performance evaluation)

przeprowadzenie badań klinicznych Panelu PBC systemu BACTEROMIC (performance evaluation)

Status

Ongoing

Signing date

—

Term

—

Source announcement →

Biomedica Medizinprodukte GmbH

undisclosed

Nowa · ramowa umowa dystrybucyjna systemów BACTEROMIC i paneli diagnostycznych

ramowa umowa dystrybucyjna systemów BACTEROMIC i paneli diagnostycznych

Status

Ongoing

Signing date

—

Term

—

Source announcement →

Mefamed Tbbi Ürünler ve Cihazlar San. Tic. Ltd. Şti.

undisclosed

Nowa · dystrybucja systemów BACTEROMIC

dystrybucja systemów BACTEROMIC

Status

Ongoing

Signing date

—

Term

—

Source announcement →

PARP (Hybolic sp. z o.o.)

14.4 m PLN

Nowa · Umowa o dofinansowanie projektu Hybolic

Umowa o dofinansowanie projektu Hybolic

Status

Ongoing

Signing date

September 28, 2026

Term

—

Report H1 2026

Trzeci dystrybutor w Europie

undisclosed

Nowa · Dystrybucja systemu BACTEROMIC

Dystrybucja systemu BACTEROMIC

Status

Ongoing

Signing date

July 01, 2026

Term

—

Report H1 2026

SHOWING 1–6 OF 6

Portfolio summary

Contracts

Active

Total value

14.4 m PLN

Average value

14.4 m PLN

Since

July 01, 2026

Where this data comes from

Contracts come from current reports (ESPI/EBI) — the company discloses only those exceeding its materiality threshold. The list is by definition incomplete.

Status — inferred from the event type and the term's end date, not a dedicated source field.

Share of revenue 12M — only when both the contracts' dominant currency and the company's reporting currency are PLN, with no currency conversion.

Contracts

SC ELTA 90 Medical Research SRL (ELTA MR)

COMAC Medical Ltd.

Biomedica Medizinprodukte GmbH

Mefamed Tbbi Ürünler ve Cihazlar San. Tic. Ltd. Şti.

PARP (Hybolic sp. z o.o.)

Trzeci dystrybutor w Europie

Portfolio summary

Where this data comes from

See also